TL
AVNS

Tirschwell & Loewy’s Avanos Medical AVNS Stock Holding History

Tirschwell & Loewy’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,859
Closed -$357K – 84
2014
Q4 		$357K Buy
+7,859
New +$309K 0.06% 75

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Tirschwell & Loewy's AVNS Position: Q1 2015 in Review

Tirschwell & Loewy sold out of Avanos Medical (AVNS) in Q1 2015, closing a stake of 7,859 shares — an estimated $357K sold.

Tirschwell & Loewy first reported a position in AVNS in Q4 2014 and held it in 1 quarter. The position peaked at $357K in Q4 2014. 448 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

  • Tirschwell & Loewy reported no remaining Avanos Medical position as of Q1 2015 after selling out during the quarter.
  • Tirschwell & Loewy sold 7,859 Avanos Medical shares in Q1 2015, an estimated $357K.
  • Tirschwell & Loewy first reported a position in Avanos Medical in Q4 2014 and held it in 1 quarter.
  • Tirschwell & Loewy's Avanos Medical position peaked at $357K in Q4 2014.
  • 448 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Tirschwell & Loewy's 13F filing for Q1 2015, filed 22 Apr 2015.